Epigenetic Alterations in Pancreatic Cancer Metastasis
Pancreatic cancer is the third leading cause of cancer-related deaths in the United States. Pancreatic ductal adenocarcinoma (PDA) is the most common (90%) and aggressive type of pancreatic cancer. Genomic analyses of PDA specimens have identified the recurrent genetic mutations that drive PDA initi...
Main Authors: | Sarah S. Wang, Jihao Xu, Keely Y. Ji, Chang-Il Hwang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/11/8/1082 |
Similar Items
-
Clinical Utility of Epigenetic Changes in Pancreatic Adenocarcinoma
by: Joyce K. Thompson, et al.
Published: (2021-09-01) -
Exploring Potential Epigenetic Biomarkers for Colorectal Cancer Metastasis
by: Priyadarshana Ajithkumar, et al.
Published: (2024-01-01) -
Selective epigenetic alterations in RNF43 in pancreatic exocrine cells from high-fat-diet-induced obese mice; implications for pancreatic cancer
by: Tomoyuki Araki, et al.
Published: (2024-04-01) -
Coming in the Air: Hypoxia Meets Epigenetics in Pancreatic Cancer
by: Claudia Geismann, et al.
Published: (2020-10-01) -
Roles of Epigenetic Modifications in the Differentiation and Function of Pancreatic β-Cells
by: Fei Xu, et al.
Published: (2020-08-01)